This paper is only available as a PDF. To read, Please Download here.
Abstract
Adult rats were fed 0.91 mM. (58.3 mg. per kilogram per 24 hours) neomycin in drinking
water for 4 weeks, and the dosage was doubled three times at 4 week intervals to a
maximum of 7.28 mM. (333.9 mg. per kilogram per 24 hours). No abnormalities were noted
in weight gain, in xylose absorption, or in morphology of the small bowel. Animals
fed 0.91 mM. neomycin for 1 year showed no change in glucose absorption during perfusion
of the small bowel when compared to a control group. However, in animals fed only
pellets and water, the addition of neomycin to the perfusate at a level of 1.2 mM.
enhanced glucose absorption by 25 to 36 per cent. Increasing the concentration to
6.0 mM. had no effect while 12.0 mM. neomycin reduced glucose absorption by 12 per
cent. It is suggested that the discrepant findings of neomycin on absorption are related
to dosage and the readily reversible effects on the mucosal cell surface.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Translational ResearchAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Effect of neomycin alteration of the rat intestinal flora on serum cholesterol and valvular sudanophilia.J. Lab. & Clin. Med. 1960; 55: 55
- Occurrence of a sprue-like syndrome during neomycin therapy.J. Clin. Invest. 1958; 37: 893
- An experimental malabsorption syndrome induced by neomycin.Am. J. Med. 1960; 28: 524
- Malabsorptive effects of neomycin in commonly used doses.J. A. M. A. 1961; 175: 187
- Malabsorptive syndrome induced by neomycin: Morphologic alterations in the jejunal mucosa.J. Lab. & Clin. Med. 1960; 56: 245
- Intestinal absorption and urinary excretion of xylose in rats fed reduced protein and thyroxine or alcohol.Gastroenterology. 1961; 41: 24
- A photometric method for the determination of free pentoses in animal tissues.J. Biol. Chem. 1948; 173: 507
- Absorption of drugs from the rat small intestine.J. Pharmacol. & Exper. Therap. 1958; 123: 81
- Validity of polyethylene glycol in estimating intestinal water volume.Gastroenterology. 1963; 44: 761
- A photometric adaptation of the Somogyi method for the determination of glucose.J. Biol. Chem. 1944; 153: 375
- A turbidometric method for the determination of higher polyethylene glycols in biological materials.Ann. Agr. Coll. (Swed.). 1955; 22: 139
- Effect of fat-poor diet upon neomycin induced malabsorption.Gastroenterology. 1964; 47: 161
- Intestinal disaccharidase content.South. M. Bull. 1965; 53 (Abst.): 25
- Intestinal lactase deficiency and saccharide malabsorption produced by oral neomycin.Am. Soc. Clin. Invest. 1966; 58 (Abst.): 133
- Malabsorption induced by small doses of neomycin sulphate.Acta med. scandinav. 1963; 173: 699
- Some observations on the enzyme histochemistry of the small intestine in human malabsorption states, with some experimental studies on the effect of neomycin in rats.Acta gastroenteral. Belg. 1964; 27: 537
- Influence of neomycin and ingested endotoxin in the pathogenesis of choline deficiency in the adult rat.J. Exper. Med. 1964; 119: 63
- The effect of oral neomycin on the rat intestine.Gastroenterologia. 1966; 105: 129
- The effect of cetyltrimethyl ammonium bromide and some related compounds on transport and metabolism in the intestine of the rat in vitro.J. Physiol. 1963; 165: 199
- Antimicrobial chemotherapeutic agents: The nature of their action and selective toxicity.New England J. Med. 1963; 269: 900
Article info
Publication history
Accepted:
February 6,
1967
Received:
October 7,
1966
Footnotes
☆Supported by Research Grants T1 AM 5320, National Institute of Arthritis and Metabolic Diseases; CA 02090 and CA 04486, National Cancer Institute; and GMO 9628, National Institute of General Medical Sciences, National Institutes of Health.
Identification
Copyright
© 1967 Published by Elsevier Inc.